Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial seque...
Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties. We assessed the benefits and harms of AT III in critically ill patients.
Methods
We searched from inception to 27 August 2015 in CENTRAL, MEDLINE, EMBASE, CAB, BIOSIS and CINAHL. We included randomized controlled trials (RCTs) irrespective of publicati...
Alternative Titles
Full title
Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7095103
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7095103
Other Identifiers
ISSN
0342-4642
E-ISSN
1432-1238
DOI
10.1007/s00134-016-4225-7
